Blue toe syndrome, severe haemophilia A and emicizumab

HaemophiliaEarly View LETTER TO THE EDITOR Blue toe syndrome, severe haemophilia A and emicizumab Patrícia Santos Resende Cardoso, Patrícia Santos Resende Cardoso orcid.org/0009-0001-0693-0693 Hematology and Oncology Unit, University Hospital, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil Hematology, HEMOMINAS Foundation, Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorCamila Beatriz Pereira Gomes da Silva, Camila Beatriz Pereira Gomes da Silva Haemostasis and Thrombosis Study Group, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorEliabe Silva de Abreu, Eliabe Silva de Abreu Haemostasis and Thrombosis Study Group, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorAndrea Gonçalves Oliveira, Andrea Gonçalves Oliveira Hematology, HEMOMINAS Foundation, Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorIsabel Figueiredo de Magalhães Pereira, Isabel Figueiredo de Magalhães Pereira Vascular Surgery, University Hospital, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorTúlio Pinho Navarro, Túlio Pinho Navarro Department of Surgery, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorSuely Meireles Rezende, Corresponding Author Suely Meireles Rezende [email protected] [email protected] orcid.org/0000-0002-3083-7093 Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil Correspondence Suely Meireles Rezende, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Av Alfredo Balena, 190, Room 255, ZIP 30.130-100, Belo Horizonte, Minas Gerais, Brazil. Email: [email protected], [email protected]Search for more papers by this author Patrícia Santos Resende Cardoso, Patrícia Santos Resende Cardoso orcid.org/0009-0001-0693-0693 Hematology and Oncology Unit, University Hospital, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil Hematology, HEMOMINAS Foundation, Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorCamila Beatriz Pereira Gomes da Silva, Camila Beatriz Pereira Gomes da Silva Haemostasis and Thrombosis Study Group, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorEliabe Silva de Abreu, Eliabe Silva de Abreu Haemostasis and Thrombosis Study Group, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorAndrea Gonçalves Oliveira, Andrea Gonçalves Oliveira Hematology, HEMOMINAS Foundation, Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorIsabel Figueiredo de Magalhães Pereira, Isabel Figueiredo de Magalhães Pereira Vascular Surgery, University Hospital, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorTúlio Pinho Navarro, Túlio Pinho Navarro Department of Surgery, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorSuely Meireles Rezende, Corresponding Author Suely Meireles Rezende [email protected] [email protected] orcid.org/0000-0002-3083-7093 Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil Correspondence Suely Meireles Rezende, Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Av Alfredo Balena, 190, Room 255, ZIP 30.130-100, Belo Horizonte, Minas Gerais, Brazil. Email: [email protected], [email protected]Search for more papers by this author First published: 23 October 2023 https://doi.org/10.1111/hae.14893Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1Pio SF, Oliveira GCde, Rezende SM. As bases moleculares da hemofilia A. Rev Assoc Med Bras. 2009; 55(2): 213-219. 2Bhardwaj R, Rath G, Goyal AK. Advancement in the treatment of haemophilia. Int J Biol Macromol. 2018; 118(Pt A): 289-295. 3Oldenburg J, Mahlangu JN, Kim B, et al. Emicizumab prophylaxis in hemophilia A with inhibitors. N Engl J Med. 2017; 377(9): 809-818. 4Mahlangu J, Oldenburg J, Paz-Priel I, et al. Emicizumab prophylaxis in patients who have hemophilia A without inhibitors. N Engl J Med. 2018; 379(9): 811-822. 5Jiménez-Yuste V, Peyvandi F, Klamroth R, et al. Safety and efficacy of long-term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: a phase 3b, multicenter, single-arm study (STASEY). Res Pract Thromb Haemost. 2022; 6(8):e12837. 6Hirschmann JV, Raugi GJ. Blue (or purple) toe syndrome. J Am Acad Dermatol. 2009; 60(1): 1-20. 7Sharifkazemi MB, Zamirian M, Aslani A. Blue toe syndrome. J Cardiovasc Med. 2007; 8(11): 975-976. 8Callaghan MU, Negrier C, Paz-Priel I, et al. Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1–4 studies. Blood. 2021; 137(16): 2231-2242. 9Larsen JB, Nielsen KBJ, Poulsen LH, Bor MV. Arterial and venous thrombosis in haemophilia patients: experiences from a Danish Haemophilia Centre. Acta Haematol. 2017; 138(2): 91-95. 10Dargaud Y, Meunier S, Negrier C. Haemophilia and thrombophilia: an unexpected association. Haemophilia. 2004; 10(4): 319-326. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation